Indomethacin induces apoptosis via a MRP1-dependent mechanism in doxorubicin-resistant small-cell lung cancer cells overexpressing MRP1
Open Access
- 16 October 2007
- journal article
- Published by Springer Science and Business Media LLC in British Journal of Cancer
- Vol. 97 (8), 1077-1083
- https://doi.org/10.1038/sj.bjc.6604010
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- Molecular mechanisms of reduced glutathione transport: role of the MRP/CFTR/ABCC and OATP/SLC21A families of membrane proteinsToxicology and Applied Pharmacology, 2005
- Verapamil and Its Derivative Trigger Apoptosis through Glutathione Extrusion by Multidrug Resistance Protein MRP1Cancer Research, 2004
- Role of mitochondrial membrane permeabilization in apoptosis and cancerOncogene, 2004
- Recurrent small cell lung cancer: UpdateSeminars in Oncology, 2003
- Structure–activity relationship of indomethacin analogues for MRP-1, COX-1 and COX-2 inhibition: identification of novel chemotherapeutic drug resistance modulatorsEuropean Journal of Cancer, 2002
- Role of glutathione depletion and reactive oxygen species generation in apoptotic signaling in a human B lymphoma cell lineCell Death & Differentiation, 2002
- Oxidative stress and apoptosisPathophysiology, 2000
- Selective Potentiation of Drug Cytotoxicity by NSAID in Human Glioma Cells: The Role of COX-1 and MRPBiochemical and Biophysical Research Communications, 1999
- Combinedin vitro modulation of adriamycin resistanceInternational Journal of Cancer, 1991
- Influence of Docosahexaenoic Acid on Cisplatin Resistance in a Human Small Cell Lung Carcinoma Cell LineJNCI Journal of the National Cancer Institute, 1989